Aposcience
Pre-clinicalAposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be functionally restored, rather than just repaired.
Founded
2013
Focus
BiologicsDiagnosticsCell & Gene Therapy
About
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be functionally restored, rather than just repaired.
Funding History
2Total raised: $10.5M
Series A$8Maws GründerfondsMar 15, 2021
Seed$2.5Maws GründerfondsJun 15, 2018
Company Info
TypePrivate
Founded2013
LocationGraz, Austria
StagePre-clinical
Contact
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile